{"podcast":{"title":"The Uromigos","slug":"the-uromigos-1214845","podcast_index_feed_id":1214845,"rss_url":"https://anchor.fm/s/13347ea8/podcast/rss","website_url":"https://www.uromigos.org","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/3122074/3122074-1626815623969-26c22e1d3574c.jpg","author":"The Uromigos","episode_count":479,"summary":"Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London","last_synced_at":"2026-07-13T22:19:20.611456+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845"},"episode":{"title":"Episode 500: RAS Inhibition in Pancreatic Cancer (yes this is the Uromigos podcast..)","slug":"episode-500-ras-inhibition-in-pancreatic-cancer-yes-this-is-the-uromigos-podcast","published_at":"2026-05-11T17:46:58+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-500-ras-inhibition-in-pancreatic-cancer-yes-this-is-the-uromigos-podcast","show_page_url":"https://stenobird.com/podcast/the-uromigos-1214845","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-500-RAS-Inhibition-in-Pancreatic-Cancer-yes-this-is-the-Uromigos-podcast-e3j7h0g","audio_url":"https://anchor.fm/s/13347ea8/podcast/play/119833040/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-11%2F423941717-44100-2-4354664512fed.m4a","summary":"Filippo Pietrantonio from the National Cancer Institute of Milan joins the podcast to discuss the latest developments in RAS targeting in GI cancers, focusing on the exciting data with daraxonrasib in pancreatic cancer ahead of the ASCO 2026 plenary phase 3 data. We discuss the RAS pathway, prior unsuccessful targeting efforts and nuances on response and resistance.","meta_description":"Filippo Pietrantonio from the National Cancer Institute of Milan joins the podcast to discuss the latest developments in RAS targeting in GI cancers, focu…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2116,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-500-ras-inhibition-in-pancreatic-cancer-yes-this-is-the-uromigos-podcast/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-500-ras-inhibition-in-pancreatic-cancer-yes-this-is-the-uromigos-podcast.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}